Article (Scientific journals)
Intravenous abciximab as a rescue therapy for immediate reocclusion after successful mechanical thrombectomy in acute ischemic stroke patients.
Delvoye, François; Loyau, Stephane; Labreuche, Julien et al.
2022In Platelets, 33 (2), p. 285 - 290
Peer Reviewed verified by ORBi
 

Files


Full Text
Intravenous abciximab as a rescue therapy for immediate reocclusion after successful mechanical thrombectomy in acute ischemic stroke patients.pdf
Author postprint (2.5 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Abciximab; Antiplatelet Therapy; Large Vessel Occlusion; Mechanical Thrombectomy; Reocclusion; Platelet Aggregation Inhibitors; Abciximab/pharmacology; Abciximab/therapeutic use; Acute Disease; Administration, Intravenous/methods; Aged; Female; Humans; Ischemic Stroke/drug therapy; Ischemic Stroke/surgery; Male; Middle Aged; Platelet Aggregation Inhibitors/pharmacology; Platelet Aggregation Inhibitors/therapeutic use; Thrombectomy/methods; Administration, Intravenous; Ischemic Stroke; Thrombectomy; Hematology
Abstract :
[en] Immediate reocclusion after mechanical thrombectomy (MT) for acute ischemic stroke (AIS) is a rare but devastating condition associated with poor functional outcome. The aim of this study was to gain insights into the mechanisms underlying immediate reocclusion, and to evaluate the efficacy and safety of the glycoprotein IIb/IIIa antagonist abciximab, for its treatment. Clinical data were collected from April 2015 to April 2019 in a monocentric prospective registry of AIS patients treated by MT. All patients with immediate reocclusion were retrospectively selected and subdivided into 2 groups according to abciximab treatment status. In vitro, the separate and combined effects of abciximab and alteplase on clot formation in whole blood under flow conditions were further investigated in microfluidic chambers. From 929 MT-treated patients, 21 had post-MT immediate reocclusion. Abciximab treatment in reocclusion patients (n = 10) led to higher rate of final recanalization (p < .001) while it did not increase bleeding complications. Flow chamber experiments revealed that, in contrast to alteplase, abciximab efficiently limits thrombus accretion from flowing blood by blocking platelet aggregation. Our results underscore a key role for platelet aggregation and the potential of Glycoprotein IIb/IIIa antagonists as a rescue therapy in post-MT immediate reocclusion.
Disciplines :
Neurology
Author, co-author :
Delvoye, François  ;  Université de Liège - ULiège > Département des sciences cliniques ; Rothschild Foundation Hospital, Interventional Neuroradiology Department, Paris, France
Loyau, Stephane;  Laboratory of Vascular Translational Science, U1148 INSERM, Université De Paris, Paris, France
Labreuche, Julien;  Lille, France
Taylor, Guillaume;  Rothschild Foundation Hospital, Intensive Care Department, Paris, France
Maier, Benjamin;  Rothschild Foundation Hospital, Interventional Neuroradiology Department, Paris, France ; Laboratory of Vascular Translational Science, U1148 INSERM, Université De Paris, Paris, France
Piotin, Michel;  Rothschild Foundation Hospital, Interventional Neuroradiology Department, Paris, France ; Laboratory of Vascular Translational Science, U1148 INSERM, Université De Paris, Paris, France
Blanc, Raphael;  Rothschild Foundation Hospital, Interventional Neuroradiology Department, Paris, France ; Laboratory of Vascular Translational Science, U1148 INSERM, Université De Paris, Paris, France
Escalard, Simon;  Rothschild Foundation Hospital, Interventional Neuroradiology Department, Paris, France
Di Meglio, Lucas;  Laboratory of Vascular Translational Science, U1148 INSERM, Université De Paris, Paris, France
Ben Maacha, Malek;  Clinical Research Unit, Rothschild Foundation Hospital, Paris, France
Redjem, Hocine;  Rothschild Foundation Hospital, Interventional Neuroradiology Department, Paris, France
Smajda, Stanislas;  Rothschild Foundation Hospital, Interventional Neuroradiology Department, Paris, France
Ciccio, Gabriele;  Rothschild Foundation Hospital, Interventional Neuroradiology Department, Paris, France
Hébert, Solène;  Rothschild Foundation Hospital, Interventional Neuroradiology Department, Paris, France
Sabben, Candice;  Rothschild Foundation Hospital, Neurology Department, Paris, France
Jandrot-Perrus, Martine;  Laboratory of Vascular Translational Science, U1148 INSERM, Université De Paris, Paris, France
Maertens de Noordhout, Alain  ;  Université de Liège - ULiège > Département des sciences cliniques
Mazighi, Mikael;  Rothschild Foundation Hospital, Interventional Neuroradiology Department, Paris, France ; Laboratory of Vascular Translational Science, U1148 INSERM, Université De Paris, Paris, France ; Université De Paris, France ; DHU Neurovasc
Ho-Tin-Noé, Benoit;  Laboratory of Vascular Translational Science, U1148 INSERM, Université De Paris, Paris, France
Desilles, Jean-Philippe;  Rothschild Foundation Hospital, Interventional Neuroradiology Department, Paris, France ; Laboratory of Vascular Translational Science, U1148 INSERM, Université De Paris, Paris, France ; Université De Paris, France
More authors (10 more) Less
Language :
English
Title :
Intravenous abciximab as a rescue therapy for immediate reocclusion after successful mechanical thrombectomy in acute ischemic stroke patients.
Publication date :
17 February 2022
Journal title :
Platelets
ISSN :
0953-7104
eISSN :
1369-1635
Publisher :
Taylor and Francis Ltd., England
Volume :
33
Issue :
2
Pages :
285 - 290
Peer reviewed :
Peer Reviewed verified by ORBi
Funding text :
This work was supported by INSERM and La Fondation pour la Recherche Médicale (grant #DPC20171138959).
Available on ORBi :
since 25 November 2024

Statistics


Number of views
10 (1 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
8
Scopus citations®
without self-citations
6
OpenCitations
 
3
OpenAlex citations
 
9

Bibliography


Similar publications



Contact ORBi